Revolutionizing Personalized Medicine with Big Data Analytics
Researchers from the Dhirubhai Ambani Institute of Information and Communication Technology in Gujarat, India, have published a report on the potential of big data analytics in personalized cardiovascular healthcare. The study highlights the importance of leveraging large datasets to understand disease mechanisms, improve patient care, and reduce the burden of cardiovascular disease. The researchers propose the integration of big data analytics with genomic, proteomic, and lifestyle data to create more effective risk stratification and personalized treatment plans.
Key Takeaways:
- The study emphasizes the need for a paradigm shift in cardiovascular research and treatment, incorporating big data analytics to improve patient outcomes.
- The researchers used machine learning, artificial intelligence, and artificial neural networks to analyze existing models of big data analytics for cardiovascular disease prediction.
- The study highlights the potential of big data analytics to guide drug selection and dosing, leading to improved patient outcomes.
- The researchers propose predictive modeling to help in the development of personalized medicines, particularly in pharmacogenomics.
- The study suggests that by leveraging the power of big data, researchers and clinicians can gain deeper insights into disease mechanisms and improve patient care.
- The researchers identified potential pitfalls and advantages of various big data analytics models, including the need for wide-ranging data sources and responsible data collection and analysis practices.
- The study emphasizes the importance of integrating big data analytics with other areas of research, such as genomics and proteomics, to create more effective personalized treatment plans.
Statistics:
- Cardiovascular diseases are attributed to a combination of various risk factors, including sedentary lifestyle, obesity, diabetes, dyslipidaemia, and hypertension.
- The researchers searched PubMed and published research using the Google and Cochrane search engines to evaluate existing models of big data analytics for cardiovascular disease prediction.
- The study proposes predictive modeling to help in the development of personalized medicines, particularly in pharmacogenomics, which could lead to improved patient outcomes.
- The researchers suggest that by leveraging the power of big data, researchers and clinicians can gain deeper insights into disease mechanisms, improving patient care and reducing the burden of cardiovascular disease.
Sources:
- "Revolutionizing Utility of Big Data Analytics in Personalized Cardiovascular Healthcare." Bioengineering, 2025,12(5):463. (Bioengineering - http://www.mdpi.com/journal/bioengineering)
- NewsRx. Research on Personalized Medicine Published by Researchers at Dhirubhai Ambani Institute of Information and Communication Technology (Revolutionizing Utility of Big Data Analytics in Personalized Cardiovascular Healthcare). Obesity & Diabetes Week. June 9, 2025; p 136.